Literature DB >> 19345152

G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo.

Han C Toh1, Li Sun, Yatanar Soe, Yonghui Wu, Yee P Phoon, Whay K Chia, Jeanie Wu, Kee Y Wong, Patrick Tan.   

Abstract

G-CSF can induce functional immune tolerance in man. In this study, purified T cells from G-CSF-mobilized peripheral blood stem cell (PBSC) donors were analysed by gene expression profiling and immunophenotyping. Results suggested a predominantly immune tolerant profile with upregulation of genes related to Th2 and Treg cells, downregulation of genes associated with Th1 cells, cytotoxicity, antigen presentation and graft-versus-host disease (GVHD) and overexpression of negative regulators of Th17 differentiation. Immunophenotyping revealed that during G-CSF exposure donors had reduced levels of T cells with a Th17 phenotype (CD4+IL-17A+CCR6+IL-23R+), more than three times lower compared to normal controls. G-CSF also led to increased levels of CD4+CD25highCD45RO+ Treg cells. Furthermore, mRNA levels of RORgammat, a Th17-specific transcription factor, decreased in T cells isolated from G-CSF-mobilized PBSC harvests. Th17 cells have been implicated in autoimmune diseases and GVHD pathophysiology. Our study is the first to report the effect of G-CSF on the Th17 subpopulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345152     DOI: 10.1016/j.clim.2009.03.509

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  17 in total

Review 1.  The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis.

Authors:  Andrew Martins; Jiahuai Han; Sung O Kim
Journal:  IUBMB Life       Date:  2010-08       Impact factor: 3.885

2.  Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza.

Authors:  Raquel Almansa; Lorenzo Socias; Paula Ramirez; Ignacio Martin-Loeches; Jordi Vallés; Ana Loza; Jordi Rello; David J Kelvin; Cristobal León; Jesús Blanco; David Andaluz; Dariela Micheloud; Enrique Maraví; Raul Ortiz de Lejarazu; Jesus F Bermejo-Martin
Journal:  Crit Care       Date:  2011-10-20       Impact factor: 9.097

Review 3.  The IL-17 differentiation pathway and its role in transplant outcome.

Authors:  Jonathan S Serody; Geoffrey R Hill
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

4.  Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.

Authors:  C E Bunse; S Tischer; J Lahrberg; M Oelke; C Figueiredo; R Blasczyk; B Eiz-Vesper
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

5.  Combined GM-CSF and G-CSF administration mobilizes CD4+ CD25hi Foxp3hi Treg in leukapheresis products of rhesus monkeys.

Authors:  Kazuki Sasaki; Yu-Chao Wang; Lien Lu; Julia Hughes; Veronica Vujevich; Angus W Thomson; Mohamed B Ezzelarab
Journal:  Am J Transplant       Date:  2020-01-20       Impact factor: 8.086

6.  Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.

Authors:  Yu Xiong; Manon Mouginot; Loic Reppel; Chongsheng Qian; Jean-Francois Stoltz; Danièle Bensoussan; Véronique Decot
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

Review 7.  Regulators of G protein signaling in cardiovascular function during pregnancy.

Authors:  Katherine J Perschbacher; Guorui Deng; Rory A Fisher; Katherine N Gibson-Corley; Mark K Santillan; Justin L Grobe
Journal:  Physiol Genomics       Date:  2018-04-27       Impact factor: 3.107

8.  Th2 polarization in target organs is involved in the alleviation of pathological damage mediated by transplanting granulocyte colony-stimulating factor-primed donor T cells.

Authors:  Yang Zhou; Leqing Cao; Huidong Guo; Yan Hong; Ming Wang; Ke Wang; Xiaojun Huang; Yingjun Chang
Journal:  Sci China Life Sci       Date:  2020-09-01       Impact factor: 6.038

9.  Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.

Authors:  Britta Eiz-Vesper; Britta Maecker-Kolhoff; Rainer Blasczyk
Journal:  Front Immunol       Date:  2013-01-28       Impact factor: 7.561

Review 10.  G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.

Authors:  Ioannis Karagiannidis; Eralda Salataj; Erika Said Abu Egal; Ellen J Beswick
Journal:  Cytokine       Date:  2021-03-04       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.